A phase 2a double-blind, placebo-controlled randomized clinical trial to evaluate immunogenicity & safety of a Zika virus vaccine (Bbv121) in Dengue sero-negative & dengue sero-negative & Dengue sero-positive healthy adults

Accessibility Controls

Principal Investigator

Mr. M.V. Murhekar Director All India Institute of Medical Sciences Delhi

Indian Council of Medical Research (ICMR)

Area of Research

Medical Sciences

Focus Area

Task Force (TF)

Start Date

2020

End Date

2021

Duration

Status

Completed

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls